Conversion From Fast Acting Oral Opioids to Abstral®

NCT01315886 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment difficulties

Conditions

Interventions

Sponsor

Orexo AB